Trice was founded to fundamentally improve orthopedic diagnostics for the patient, physician, and payer by providing instant, eyes-on, answers. Trice has pioneered fully integrated camera-enabled needle technologies that provide a clinical solution that is optimized for the physician™s office. Trice's mission is to provide more immediate and definitive patient care, eliminating the false reads associated with current indirect modalities and significantly reduce the overall cost to the healthcare system.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/17/14 | $11,600,000 | Series B |
BioStar Ventures | undisclosed |
| 06/06/17 | $19,300,000 | Series C |
BioStar Ventures HealthQuest Capital Safeguard Scientifics Smith & Nephew  | undisclosed |
